Europe Breast Cancer Screening Market was valued at USD 1.12 billion in 2024 and is predicted to reach USD 2.43 billion by 2033, growing at a CAGR of 9.02% from 2025 to 2033. The market is driven by increasing awareness about early cancer detection, advancements in screening technologies, and government initiatives promoting regular breast cancer screenings. The rising prevalence of breast cancer and improved access to healthcare facilities further contribute to market growth.